Stock data
Kyntra Bio, Inc. (KYNB)
Kyntra Bio, Inc. (KYNB) reported revenue of US$6.44M and net income of US$183.45M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$6.44M | — | -US$45.90M | US$183.45M | — |
| 2024 | US$29.62M | — | -US$150.42M | -US$47.58M | — |
| 2023 | US$46.80M | — | -US$322.72M | -US$284.23M | — |
| 2022 | US$140.73M | — | -US$301.02M | -US$293.65M | — |
| 2021 | US$235.31M | — | -US$288.53M | -US$290.02M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | -US$1.47M | US$11.97M | — |
| 2026-03-31 | US$3.74M | -US$15.20M | — |
| 2025-12-31 | US$1.28M | -US$14.22M | — |
| 2025-09-30 | US$1.08M | US$200.64M | — |
| 2025-06-30 | US$1.35M | -US$7.60M | — |
| 2025-03-31 | US$2.74M | US$4.64M | — |
| 2024-12-31 | US$3.14M | US$17.98M | — |
| 2024-09-30 | US$0.12M | -US$17.08M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.